CARMEL,
Ind., May 2, 2024 /PRNewswire/ -- Syra Health
Corp. (NASDAQ: SYRA), a healthcare technology company with a
mission to improve healthcare by providing innovative services and
technology solutions, announced today it has presented the
nonprofit organization Overdose Lifeline with the inaugural Syra
Health Mental and Behavioral Health Solutions Award.
An independent psychiatrist, Dr. Bethany
Richards, who oversaw the selection process, said Overdose
Lifeline was chosen based on the award criteria. "Overdose Lifeline
is an established advocacy group that offers education and
resources on substance abuse to diverse communities. The
organization focuses particularly on combating the opioid crisis,
as well as utilizing social media platforms to promote the
destigmatization of mental health issues."
According to the National Institute of Mental Health, Substance
Use Disorder (SUD) is a treatable mental disorder that affects a
person's brain and behavior, leading to their inability to control
their use of substances like legal or illegal drugs, alcohol, or
medications. Symptoms can be moderate to severe with addiction
being the most severe form of SUD. People with SUD may also have
other mental health disorders, such as anxiety, or depression.
"We were proud to present the inaugural Syra Health Mental and
Behavioral Health Solutions Award to Overdose Lifeline," said Dr.
Deepika Vuppalanchi, CEO,
Syra Health. "There are gaps in
mental health treatment that can only be filled by advocacy groups
like Overdose Lifeline in collaboration with companies like ours
that are focused on the technology interventions, while always
keeping the individual suffering at the heart of our
solutions."
Syra Health presented the inaugural Syra Health Mental and
Behavioral Health Solutions Award during Syra's Mental Health
Solutions Day, showcasing solutions to the mental health crisis in
America. Syra Health expects to host the event and present its
award on an annual basis.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company addressing some
of healthcare's most significant challenges in areas such
as behavioral and mental health, digital health,
and population health, by providing innovative services and
technology solutions. Syra Health's products and services are
centered on prevention, improved access, and affordable care. Syra
Health supplies its solutions to payers, providers, life sciences
organizations, academic institutions, and government. For more
information, please visit www.syrahealth.com.
FORWARD-LOOKING STATEMENTS
Statements in this press release about future expectations,
plans, and prospects, as well as any other statements regarding
matters that are not historical facts, may constitute
"forward-looking statements." These statements include, but are not
limited to, statements relating to the expected use of proceeds,
the Company's operations and business strategy and the Company's
expected financial results. The words "anticipate," "believe,"
"continue," "could," "estimate," "expect," "intend," "may," "plan,"
"potential," "predict," "project," "should," "target," "will,"
"would" and similar expressions are intended to identify
forward-looking statements, although not all forward-looking
statements contain these identifying words. The forward-looking
statements contained in this press release are based on
management's current expectations and are subject to substantial
risks, uncertainty and changes in circumstances. Investors should
read the risk factors set forth in our registration statement on
Form S-1 and other periodic reports filed with the Securities and
Exchange Commission. Any forward-looking statements contained in
this press release speak only as of the date hereof, and, except as
required by federal securities laws, the Company specifically
disclaims any obligation to update any forward-looking statements,
whether as a result of new information, future events, or
otherwise.
For more information, please contact:
For Media Inquiries:
Christine
Drury
Communications and Marketing Director
Syra Health
463-345-5180
christined@syrahealth.com
For Investor Inquiries:
Ben
Shamsian
Vice President
Lytham Partners, LLC
646-829-9701
shamsian@lythampartners.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/syra-health-presents-overdose-lifeline-with-mental-and-behavioral-health-solutions-award-302134262.html
SOURCE Syra Health